| Dr Somer Johnson Lyons, OD | |
|
1687 Us Highway 395 N, #2, Minden, NV 89423-4321 | |
| (775) 783-1111 | |
| Not Available |
| Full Name | Dr Somer Johnson Lyons |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 21 Years |
| Location | 1687 Us Highway 395 N, Minden, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497725212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 489 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Somer J Lyons Od Ltd | 0042245854 | 2 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.
The process of metastasis requires that cancer cells traveling from a primary tumor find a hospitable environment in which to implant themselves and grow. A new study from Massachusetts General Hospital (MGH) Cancer Center researchers finds that circulating tumor cells prepare this environment by bringing along from their original site noncancerous cells that support tumor growth. The report has been published online in PNAS Early Edition.
Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").
› Verified 7 days ago
| Provider Name | Somer J Lyons Od Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306044110 PECOS PAC ID: 0042245854 Enrollment ID: O20090402000352 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.
The process of metastasis requires that cancer cells traveling from a primary tumor find a hospitable environment in which to implant themselves and grow. A new study from Massachusetts General Hospital (MGH) Cancer Center researchers finds that circulating tumor cells prepare this environment by bringing along from their original site noncancerous cells that support tumor growth. The report has been published online in PNAS Early Edition.
Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Somer Johnson Lyons, OD 115 Jackdaw Ln, Carson City, NV 89704-9719 Ph: () - | Dr Somer Johnson Lyons, OD 1687 Us Highway 395 N, #2, Minden, NV 89423-4321 Ph: (775) 783-1111 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
Hitachi, Ltd. and NextDocs Corporation today announced their newly formed partnership in document management solutions for pharmaceutical manufacturers.
The process of metastasis requires that cancer cells traveling from a primary tumor find a hospitable environment in which to implant themselves and grow. A new study from Massachusetts General Hospital (MGH) Cancer Center researchers finds that circulating tumor cells prepare this environment by bringing along from their original site noncancerous cells that support tumor growth. The report has been published online in PNAS Early Edition.
Intrexon Corporation, a next generation synthetic biology company, today announced an agreement with Novici Biotech LLC in which Intrexon has licensed certain non-exclusive rights to the use of Novici's patented GRAMMR® technology for high-resolution genetic reassortment ("gene shuffling").
› Verified 7 days ago
Pritchett Eye Care Associates (minden) Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1701 County Rd, Ste Q, Minden, NV 89423 Phone: 775-782-3937 Fax: 775-783-4288 | |
Valley Eyecare & Eyewear Gallery Optometrist Medicare: Medicare Enrolled Practice Location: 1644 Us Highway 395 N, Unit B-1, Minden, NV 89423 Phone: 775-783-1111 | |
Dr. Johanna Lee, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1701 County Rd Ste Q, Minden, NV 89423 Phone: 775-782-3937 |